 |
 |
Source: Viartis.com NEW METHOD OF DIAGNOSING PARKINSON'S DISEASE Transgenomic and Power3 Medical have announced the introduction of a new blood test for Parkinson's Disease called NuroProŽ PD. The NuroPro PD test can help clinicians distinguish patients with Parkinson's diseases from those that don't have Parkinson's Disease, and those people with other neurological disorders. The tests are a panel of blood serum protein biomarkers that are evaluated to predict the probability that somebody has Parkinson's Disease. The results showed that NuroPro PD was able to discriminate between Parkinson's Disease patients and age-matched control subjects with a sensitivity of 93% and specificity of 96%. Samples from Parkinson's Disease patients were correctly identified with 100% sensitivity when tested. The aim is to market NuroPro PD in the near future. For more information go to the Press release. As many as 25% of people with Parkinson's Disease are wrongly diagnosed. So a method of diagnosing Parkinson's Disease that was far more accurate than symptom questionnaires, and much cheaper than the relatively expensive scanning methods, would be a major development. For current methods of diagnosis, go to Diagnosis of Parkinson's Disease. In order to refer to this article on its own click here. Rayilyn Brown Director AZNPF Arizona Chapter National Parkinson Foundation [log in to unmask] ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn